Johnson & Johnson announces US launch of TECNIS Odyssey IOL

News
Article

The TECNIS Odyssey IOL is a new full vision range IOL built on the TECNIS platform.

Odyssey IOL packaging Image credit: Johnson & Johnson

Image credit: Johnson & Johnson

Johnson & Johnson is expanding the launch of its presbyopia-correcting intraocular lense (IOL), TECNIS Odyssey, in the US.

The TECNIS Odyssey IOL is a new full vision range IOL, built on the TECNIS platform from Johnson & Johnson, which according to the company provides two times better contrast in low lighting than PanOptix.1

Peter Menziuso, company group chairman, Vision, Johnson & Johnson, commented on the launch in a release from the company stating, “More than 14,000 eyes have already benefited from TECNIS Odyssey, our new full visual range IOL. TECNIS Odyssey patients have reported outstanding visual outcomes following surgery, which is why we are excited to announce we are expanding the roll-out across the US. Cataract surgery gives patients a once-in-a-lifetime opportunity to improve their sight, and now with this advanced IOL, patients can see clearly at every distance, without the need for glasses.”

TECNIS Odyssey IOLs feature a unique, freeform diffractive surface designed to eliminate the gaps between near, intermediate, and far distances, which offers continuous, uninterrupted vision at all distances, according to the company. Furthermore, 94% of patients who received the IOL were satisfied with their overall vision without glasses.1

In addition to the launch, Johnson & Johnson is launching the “TECNIS Odyssey IOL Peer Connect" which will allow eye care professionals to engage in live virtual clinical discussions, and will help “foster direct and meaningful medical and scientific conversations regarding TECNIS Odyssey IOL between healthcare professionals with expert surgeons who had early access to the technology.”1

In addition to the US, TECNIS Odyssey IOLs have received regulatory approval in Japan, EU, Korea, Canada, Singapore, Australia and New Zealand.

References:
  1. Johnson & Johnson Rolls Out New TECNIS Odyssey Next-Generation Intraocular Lens Offering Cataract Patients Precise Vision at Every Distance in Any Lighting. Press Release; September 30, 2024. Accessed September 30, 2024. https://www2.multivu.com/johnson-johnson/9293351-en-johnson-and-johnson-vision-tecnis-odyssey
Recent Videos
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
Agatha Sleboda, OD; Arti Shah, OD, FAAO; and Kent J. Nozacki, OD provide the best tips that they give to their patients during natural disasters events in light of the recent Greater Los Angeles wildfires.
Optometrists local to the Los Angeles area overview their efforts to continue providing support to patients affected by January's wildfires.
Brianna Rhue, OD, FAAO, FSLS, reviewed key takeaways from The Future of Myopia Management: Perspectives from Leading Experts talk from SECO 2025.
Dr. Julie Rodman discusses retina, imaging, and posterior segment in SECO presentations
Shan Lin, MD, and John Berdahl, MD, share their perspectives as ophthalmologists regarding the importance of comanagement.
Robert L. Stamper, MD, overviews his optometric track talk titled Objective Perimetry - Can you see it? at this year's Glaucoma 360 meeting.
Three EnVision Summit faculty members weigh in on the importance of comanagement in glaucoma management, where artificial intelligence will lead eye care, and what hopes are on the horizon for corneal ectasia treatments.
Yvonne Ou, MD, outlined lifestyle modifications for glaucoma management that have proven beneficial, including yoga and cycling.
© 2025 MJH Life Sciences

All rights reserved.